The role of the junctional zone in the diagnosis and treatment of adenomyosis
Journal of obstetrics and women's diseases · 29.04.2026 · 75 (2) · 54-63
DOI: 10.17816/jowd692632 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of obstetrics and women's diseases, online erschienen am 29.04.2026. Verfasst von Stanislava V. Nagorneva und 2 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Background
Timely diagnosis of adenomyosis remains important due to the high incidence of the disease among women of reproductive age. Interest in using myometrial transition zone parameters in diagnostic algorithms has persisted since the first data on it as a marker for adenomyosis emerged. However, the role and clinical significance of the junctional zone in patients with adenomyosis currently remain a subject of scientific debate due to the inconsistency of the available data. Furthermore, the literature lacks information on its dynamics and changes under the influence of various therapies.
Aim
The aim of this study was to evaluate the diagnostic significance of the junctional zone parameters in adenomyosis and their changes during the treatment of the disease.
Methods
A prospective cross-sectional, single-center study was conducted. All patients underwent ultrasound examination using an expert-class GE Voluson E10 (GE Healthcare, USA) with IC5-9-D and RIC6-12-D probes, color Doppler mapping, elastography, and volume reconstruction. To diagnose adenomyosis, we used the results of a comprehensive ultrasound examination using a patented proprietary scoring method. All patients underwent a junctional zone assessment.
Results
344 women were examined: 287 with a diagnosis of adenomyosis, of whom 273 had complaints and 14 were without complaints, and 57 patients in the control group. Significant differences were found in the assessment of the junctional zone in the main groups and the control group (p = 0.37). In 156 patients, the junctional zone was assessed before and 6 months after treatment of adenomyosis using several regimens: resveratrol 100 mg daily, dienogest 2 mg daily, and resveratrol 100 mg + dienogest 2 mg daily. During treatment, the average size of the junctional zone decreased, especially after combined treatment (p = 0.03).
Conclusion
The significance of the assessment of the junctional zone in the diagnosis of adenomyosis is currently small, due to the peculiarities of its visualization in some patients, however, the assessment of the thickness and uniformity of the junctional zone can be successfully used in the complex diagnosis of the disease. Furthermore, dynamic assessment of these parameters is a useful tool for monitoring treatment effectiveness, particularly during maintenance therapy.
Zitieren
APA
Nagorneva, S. V., Shalina, M. A., & Yarmolinskaya, M. I. (2026). The role of the junctional zone in the diagnosis and treatment of adenomyosis. Journal of obstetrics and women's diseases, 75(2), 54-63. https://doi.org/10.17816/jowd692632
Vancouver
Nagorneva SV, Shalina MA, Yarmolinskaya MI. The role of the junctional zone in the diagnosis and treatment of adenomyosis. Journal of obstetrics and women's diseases. 2026;75(2):54-63. doi:10.17816/jowd692632
BibTeX
@article{Nagorneva2026,
author = {Nagorneva, Stanislava V. and Shalina, Maria A. and Yarmolinskaya, Maria I.},
title = {The role of the junctional zone in the diagnosis and treatment of adenomyosis},
journal = {Journal of obstetrics and women's diseases},
year = {2026},
volume = {75},
number = {2},
pages = {54--63},
doi = {10.17816/jowd692632}
}
EUVIMED